Arama Sonuçları - Dadu, Ramona
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 39
- Sonraki Sayfaya Git
-
1
Unusual presentation of endocarditis with nutritional variant Streptococci Yazar: DADU, RAZVAN T., DADU, RAMONA, ZANE, SAUL
Baskı/Yayın Bilgisi 2013Metin -
2
Thyrotoxic Dysphagia in an 82-Year-Old Male Yazar: Parperis, Konstantinos, Dadu, Ramona, Hoq, Sheikh, Argento, Vivian
Baskı/Yayın Bilgisi 2011Metin -
3
In Reply Yazar: Cabanillas, Maria E., Dadu, Ramona, Lai, Stephen Y.
Baskı/Yayın Bilgisi 2014Metin -
4
-
5
-
6
-
7
Sorafenib in Metastatic Thyroid Cancer: A Systematic Review Yazar: Thomas, Ligy, Lai, Stephen Y., Dong, Wenli, Feng, Lei, Dadu, Ramona, Regone, Rachel M., Cabanillas, Maria E.
Baskı/Yayın Bilgisi 2014Metin -
8
Aerodigestive Fistula Formation as a Rare Side Effect of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Thyroid Cancer Yazar: Blevins, Dean P., Dadu, Ramona, Hu, Mimi, Baik, Christina, Balachandran, Diwakar, Ross, William, Gunn, Brandon, Cabanillas, Maria E.
Baskı/Yayın Bilgisi 2014Metin -
9
Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center Yazar: Jeun, Rebecca, Best, Conor, Iyer, Priyanka, Lavis, Victor Ralph, Varghese, Jeena Mary, Oliva, Isabella Glitza, Dadu, Ramona, Thosani, Sonali
Baskı/Yayın Bilgisi 2021Metin -
10
Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury Yazar: Abu-Sbeih, Hamzah, Tang, Tenglong, Lu, Yang, Thirumurthi, Selvi, Altan, Mehmet, Jazaeri, Amir A., Dadu, Ramona, Coronel, Emmanuel, Wang, Yinghong
Baskı/Yayın Bilgisi 2019Metin -
11
OR27-6 Combination Vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL1 Inhibitor) in BRAF-V600E Mutated Anaplastic Thyroid Cancer (ATC): Initial Safety... Yazar: Cabanillas, Maria, Busaidy, Naifa, Dadu, Ramona, Ferrarotto, Renata, Gross, Neil, Gule-Monroe, Maria, Lu, Charles, Grosu, Horiana, Williams, Michelle, Zafereo, Mark
Baskı/Yayın Bilgisi 2019Metin -
12
Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up Yazar: Dadu, Ramona, Rodgers, Theresa E, Trinh, Van A, Kemp, Elizabeth Helen, Cubb, Trisha D, Patel, Sapna, Simon, Julie M, Burton, Elizabeth M, Tawbi, Hussein
Baskı/Yayın Bilgisi 2020Metin -
13
Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer–Related Diarrhea and Its Effects on Quality of Life: A Pilot Study Yazar: Dadu, Ramona, Hu, Mimi I., Cleeland, Charles, Busaidy, Naifa L., Habra, Mouhammed, Waguespack, Steven G., Sherman, Steven I., Ying, Anita, Fox, Patricia, Cabanillas, Maria E.
Baskı/Yayın Bilgisi 2015Metin -
14
Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis Yazar: Abu-Sbeih, Hamzah, Ali, Faisal S., Wang, Xuemei, Mallepally, Niharika, Chen, Ellie, Altan, Mehmet, Bresalier, Robert S., Charabaty, Aline, Dadu, Ramona, Jazaeri, Amir, Lashner, Bret, Wang, Yinghong
Baskı/Yayın Bilgisi 2019Metin -
15
Acquired Secondary RAS Mutation in BRAF(V600E)-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors Yazar: Cabanillas, Maria E., Dadu, Ramona, Iyer, Pryianka, Wanland, Kacey B., Busaidy, Naifa L., Ying, Anita, Gule-Monroe, Maria, Wang, Jennifer R., Zafereo, Mark, Hofmann, Marie-Claude
Baskı/Yayın Bilgisi 2020Metin -
16
Immune-Related Thyroiditis with Immune Checkpoint Inhibitors Yazar: Iyer, Priyanka C., Cabanillas, Maria E., Waguespack, Steven G., Hu, Mimi I., Thosani, Sonali, Lavis, Victor R., Busaidy, Naifa L., Subudhi, Sumit K., Diab, Adi, Dadu, Ramona
Baskı/Yayın Bilgisi 2018Metin -
17
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine Yazar: Jaber, Tania, Waguespack, Steven G, Cabanillas, Maria E, Elbanan, Mohamed, Vu, Thinh, Dadu, Ramona, Sherman, Steven I, Amit, Moran, Santos, Elmer B, Zafereo, Mark, Busaidy, Naifa L
Baskı/Yayın Bilgisi 2018Metin -
18
Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer Yazar: Dadu, Ramona, Waguespack, Steven G., Sherman, Steven I., Hu, Mimi I., Busaidy, Naifa L., Jimenez, Camilo, Habra, Mohammed A., Ying, Anita K., Bassett, Roland L., Cabanillas, Maria E.
Baskı/Yayın Bilgisi 2014Metin -
19
Efficacy and Tolerability of Vemurafenib in Patients with BRAF(V600E) -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience Yazar: Dadu, Ramona, Shah, Komal, Busaidy, Naifa L., Waguespack, Steven G., Habra, Mouhammad A., Ying, Anita K., Hu, Mimi I., Bassett, Roland, Jimenez, Camilo, Sherman, Steven I., Cabanillas, Maria E.
Baskı/Yayın Bilgisi 2015Metin -
20
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma Yazar: Iyer, Priyanka C., Dadu, Ramona, Ferrarotto, Renata, Busaidy, Naifa L., Habra, Mouhammed A., Zafereo, Mark, Gross, Neil, Hess, Kenneth R., Gule-Monroe, Maria, Williams, Michelle D., Cabanillas, Maria E.
Baskı/Yayın Bilgisi 2018Metin